Dr. Faris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dartmouth-Hitchcock Medical Center
Lebanon, NH 03756
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008 - 2011
Massachusetts General HospitalChief Residency, Internal Medicine, 2010 - 2010- Massachusetts General HospitalResidency, Internal Medicine, 2005 - 2008
Johns Hopkins University School of MedicineClass of 2005
Certifications & Licensure
NH State Medical License 2019 - 2025
MA State Medical License 2007 - 2020- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Start of enrollment: 2012 Jul 01
- Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer Start of enrollment: 2012 Nov 23
- A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 95 citationsCirculating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinomaDarrell R. Borger, Lipika Goyal, Thomas Yau, Ronnie T.P. Poon, Marek Ancukiewicz
Clinical Cancer Research. 2014-04-01 - 317 citationsLiquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.Aparna Raj Parikh, Ignaty Leshchiner, Liudmila Elagina, Lipika Goyal, Chaya Levovitz
Nature Medicine. 2019-09-01 - 463 citationsRadiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.Cristina R. Ferrone, Giovanni Marchegiani, Theodore S. Hong, David P. Ryan, Vikram Deshpande
Annals of Surgery. 2015-01-01
Committees
- Editorial Board Member, National Cancer Institute Adult Treatment Editorial Board 2012 - 2015
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
